Lentinan-Based Oral Nanoparticle Loaded Budesonide With Macrophage-Targeting Ability for Treatment of Ulcerative Colitis.

Front Bioeng Biotechnol · 2021 · PMC8429481 · PMID 34513811

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

As shown in Figure 5C , DAI of the LNT/BUD-NPs group exhibited a decreasing trend and were lower than that of the DSS Model group.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.